Prevalence of patients with colorectal cancer requiring follow-up or active treatment.
Fiche publication
Date publication
mai 2009
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BOUVIER Anne-Marie, Dr JOOSTE Valérie, Pr LEPAGE Côme, Dr COTTET Vanessa
Tous les auteurs :
Chauvenet M, Lepage C, Jooste V, Cottet V, Faivre J, Bouvier AM
Lien Pubmed
Résumé
INTRODUCTION: The objective of this study was to estimate prevalence of colorectal cancers requiring care or follow-up. MATERIALS AND METHODS: Prevalence was observed in 2005 on the population-based digestive cancer registry of Burgundy (France). Total and 5-year partial prevalences were calculated. The prevalence of patients requiring follow-up was estimated using non-mixture cure models. The prevalence of patients with recurrence was estimated using annual recurrence rates. RESULTS: Total prevalence was 262,244 cases in France. The mean variation in 5-year partial prevalence between successive 5-year periods was +8.0%. Time to cure was estimated to be 9.3 years, suggesting that follow-up is needed over a 10-year period, corresponding to 71.7% of prevalent cases. In 2005, 5.4% of prevalent cases had recurrent cancer requiring treatment. CONCLUSION: This study underlines the burden of colorectal cancer on the health system. Prevalence of patients requiring follow-up or treatment provides interesting information in addition to classic indicators.
Référence
Eur J Cancer. 2009 May;45(8):1460-5